chrisvoncsefalvay/vaers-outcomes huggingface dataset:
SHORTNESS OF BREATH; CHEST CONGESTION; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced shortness of breath, and chest congestion. Treatment medications (dates unspecified) included: dextromethorphan hydrobromide/doxylamine succinate/ephedrine sulfate/ethanol/paracetamol, oxymetazoline hydrochloride, and salbutamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the chest congestion and shortness of breath was not reported. This report was non-serious. This case, from the same reporter is linked to 20211258792.; Sender's Comments: Medical assessment comment is not required as per standard procedure as case was assessed as non-serious.
Left arm was red and swollen around injection site. It felt sore and was warm to the touch. Swollen area did increase in size, patient was told to ice the area.
Pfizer vaccine was administered outside of Facility- reported by patient- ? NO LOT NUMBER WERE SUPPLIED ---------------------------------------------------------------------------------------------------------------------- T78.40XD ALLERGIC DISORDER, SUBSEQ 5/28/2021 UPPER GI HEMORRHAGE
27th  Wednesday-Jan 2021-Severe HA 28th January 2021-Thursday-HA 29th January 2021-Friday-Today-Headaches   Told to go get something for his headaches-Tylenol or motrin/ and GO to the ER if his headaches get worse
Since 2020, I have had occurrences of Atrial Flutter/Atrial Fibrillation and have undergone 2 ablations on 7/22/2020 & 9/23/2020 and the installation of the heart device on 7/20/2021. I continue to wear a cardiac monitor. A Monitor report generated this April showed only occasional PACs or rare instances of atrial flutter prior to the last vaccination. After vaccination, the report shows daily occurrences of either Atrial Flutter, Atrial Fibrillation or Tachycardia. I now take Metoprolol Tartrate 2x/day and will undergo another ablation (scheduled for June 7th) to correct it.
injection site reaction; This case was reported by a pharmacist via call center representative and described the occurrence of injection site reaction in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 24th October 2022, the patient received Shingrix. In October 2022, less than a week after receiving Shingrix, the patient experienced injection site reaction. On an unknown date, the outcome of the injection site reaction was unknown.   It was unknown if the reporter considered the injection site reaction to be related to Shingrix.   Additional Information: GSK Receipt Date: 26-OCT-2022 Reporter's Comment: The reporter reported a patient received Shingrix and developed an injection site reaction.  The vaccine administration facility was the same as primary reporter. The reporter consented to follow up. Additional Supportive Information: The case had been linked to US2021199863,reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021199863:Same reporter
After 6 hours I got an extreme headache. I haven't had migraines in years, and I started to feel them. I have a kit for high blood pressure, and I started to use it. It was ranging over 160 over 102. I had shortness of breath, it didn't last the entire day, but it would come and go. The blood pressure lasted for 10 days. I would monitor daily. On either the 25th or 26th, I sent my cardiologist an email that I didn't want to risk the second vaccine. They asked that I still take the vaccine. They wanted to figure out a medication if I did have some sort of complication. I do take 5 mile walks, it didn't happen with my walks, but when it would happen I got heaviness in my chest and I had pain on my upper right back. My medical professionals convinced me to take the second vaccine. My migraines lasted about 3 weeks.
BEING REAL SICK; This spontaneous report received from a patient via a company representative through social media and concerned a patient of unspecified age, sex, race and ethnicity. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin, batch number and expiry date were not reported) dose, start therapy date were not reported, 1 total administrated for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced being really sick, and after being sick for a week, patient visited physician's office. The physician informed that the body was trying to adjust to it (dose number in series 1).  The reporter stated "I did the same thing and ended up at the drs office after a week of being real sick. He explained it was because my body was trying to adjust to it and that was a good thing for if I had got Covid-19 I probably wouldn't survive it. I then got the booster shot and did ok. I'm glad I did get then shots." The patient additionally received booster dose of covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin, batch number and expiry date were not reported) dose, start therapy date were not reported, 1 total administrated for covid-19 prophylaxis. It was unknown whether patient had any adverse events following vaccination with covid-19 vaccine ad26.cov2.s (dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of being real sick was not reported. This report was non-serious.
Patient  reports redness and itchiness lasting 4 days. there is also slight inflammation at the site of injection. when asked, the patient said its resolving slowly but was worried about outcomes.
Information has been received from a pharmacist concerning herself, a 34 year old female who in approximately 1995 (also reported as 1997) was vaccinated with two doses of Varivax. On 15-JAN-2007, the patient had her titers checked which came back low at 0.8 (units not provided). The patient did not seek medical attention. As of 26-JAN-2007, the patient's outcome was unknown. Additional information has been requested.
Pt experienced severe headache, fever, chills for 7 days. Pt also experienced papilledema and dehydration and vomiting for 2-3 days.
Information has been received from a registered nurse concerning a female patient who on 09-AUG-2010 she was vaccinated with the second dose of GARDASIL (Lot # and route not reported). The nurse reported that the patient developed an injection site reaction including pain and swelling after receiving the second dose. She stated that the patient had pain which traveled up and down the arm. At the time of the report, the patient's outcome was unknown. It was unknown if the patient sought medical attention. Follow up information has been received from a registered nurse concerning the 18 year old female trainer with reaction to NAPROX (hives) who on 09-AUG-2010, at 11:15, was vaccinated intramuscularly with the second dose of GARDASIL (lot# 662765/0821Y) into her left deltoid. It was reported that the patient was fine post vaccination. On 24-AUG-2010 the patient developed pain and pain increased and she had trouble moving arm. She also had pain in neck and shoulder, site swollen now. The patient was advised to visit the emergency room to evaluation. In review of emergency room records, the patient did not go. At the time of this report, the patient's outcome was not reported. Follow-up information was received from a registered nurse. The patient had allergy to naproxen and had no illness at the time of vaccination. There were no other signs of illness prior to 24-AUG-2010. The patient has had extensive workup from 24-AUG-2010 to present with the primary care physician, at ENT (ear, nose and throat). The tests revealed that tonsillitis (T3), sinus infection, joint pain, headaches, negative for lupus, lyme ("x24"), negative for other tick-borne illness. They have not seen the patient since the event. It was unknown if illness 2 weeks after injection was related or not. The outcome of the events was reported as not recovered. Follow-up information has been received from the registered nurse. She stated that no information was available, they had not seen the patient since August. Additional information is not expected.
Vaccine administered Friday 6/19/15. Pt called 6/22/15 to report large, red, swollen, itching at injection site. Denies fever or any other symptoms. Says resolved now.
day following vax pt exp swelling, redness, warmth & tenderness; pt has large strawberry hemangioma below inject site;
GOT COVID; This spontaneous report received from a consumer via a company representative concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient was very exposed to close contact who have experienced covid-19. The patient's grandparent medical history included diabetes and high blood pressure. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced got covid. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of got covid was not reported. This report was non-serious. This case, from the same reporter is linked to 20220350895.
Right arm swollen from shoulder to above hand, fire red, skin hot and hard to the touch. Pain in arm. Slight dizziness and headache.
Immediately after injection, my face and body turned RED.  Nothing else. Just RED. I thought maybe BP, but never had that happen before.  I was anxious as I have anxiety disorder! But my face was RED and TIRED looking. I asked staff what wrong. No swelling at that time! 4:40 PM.  That nite, my heart started POUNDING HARD all night, not stop. Ativan not help. I slept, weird dreams, wake up and still heart pounding.  8 am --- got up and hands, arms, extremities SWOLLEN!! Heart still pounding,  Felt like allergic to MSG or nitrates or preservatives or too much salt. Felt weird.. Not faint-- just weird. Tired from the pounding heart. Not fatigued.  I did have sore arm, but it was NOT an issue.  My hands, toes were red.
After giving Flublok in the right deltoid a drop of blood ran down his arm. While putting the bandage on felt a small knot. Called the patient the next morning and he said the knot is gone and he did not have any pain or allergic symptoms.
Paresthesia (numbness/tingling) of face, arms, legs, chest, randomly throughout the day in different locations,; tremors of head and hands; tremors of hands; Twitches and spasm of head and extremities; spasm of head and extremities; dizziness, light headedness; dermatomal pains; This is a spontaneous report from a contactable nurse, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA Vaccine; Lot Number: UNKNOWN) via an unspecified route of administration on 28Aug2021 (at the age of 39-years-old) as a single dose for COVID-19 immunisation .Medical History included COVID-19. Patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19.The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included fish oil (MANUFACTURER UNKNOWN) and calcium pantothenate, nicotinamide, pyridoxine hydrochloride, riboflavin sodium phosphate, thiamine hydrochloride (VITAMIN B COMPLEX) taken for an unknown indication and unknown if ongoing.   On 01Sep2021, a few days after the vaccination, the patient experienced paresthesia (numbness/tingling) of face, arms, legs, chest, randomly throughout the day in different locations, tremors of head and hands, twitches and spasms of head and extremities, dizziness, light-headedness, dermatomal pains randomly throughout the day and had lasted about 6-7 weeks. The events resulted in doctor or other healthcare professional office/clinic. No therapeutic measures were taken as a result of the events. Since the vaccination the patient was not tested for COVID-19. The clinical outcome of the events paresthesia, tremors of head and hand, twitches and spasms of head and extremities, dizziness dermatomal pains were resolving at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
--Cardiac Symptoms. One week after Pfizer Booster:  3 times  squeezing in center of chest;  fluttering and skipping of heartbeats; unsteady on my feet;  lightheaded;  tired;  chills
Rash left upper quadrant/stomach - 4 days after vax, lasting until 10/2/2000, 2 months unrelated rash- biopsy = allergic drug reaction pain in area that runs in tissue. Started period same day - it went on for 28 days. I went to OBGYN an got a pill to make it stop.
Motor tic in neck and shoulders followed by signs of OCD and separation anxiety. Was found to have strep throat on 11/05/2012.
Redness, tenderness, swelling (L) arm site of 2 vaccines. KEFLEX 500 mg BID x 7 days. TAC oint 0.1% apply TID.
3 days post vax pt experienced facial puffiness, right arm tingling shortness of breath and hyperventilation. The pt recovered from this experience.
Per Hospital Discharge Summary: At 4 AM on 11/3/2017 patient vomited x1 then had a seizure like episode lasting approximately 45 minutes to 1 hour. Patient was taken by EMS to Medical Center and treated with 2 mg ATIVAN IV which stopped the seizure within a few minutes. Once stable, was transferred to another Hospital. Patient was diagnosed with febrile seizure with status epilepticus 2/2 MMRV vaccine. EEG and MRI were completed. EEG showed mild focal slowing in the left temporal region.
injection arm soreness; small headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (injection arm soreness) and HEADACHE (small headache) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (injection arm soreness) and HEADACHE (small headache). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) for Headache, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (injection arm soreness) and HEADACHE (small headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included diabetic medications.   This case was linked to US-sm-MOD-21-091615 (E2B Linked Report).; Sender's Comments:  US-sm-MOD-21-091615:Case Cross Linked with MOD-21091615
HR 140s; diaphoretic; feeling "weird" in chest; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the parent.  A 9 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 06Nov2021 18:30 (Lot number: FL0007) at the age of 9 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: FLU, administration date 2021. The following information was reported: HEART RATE INCREASED (non-serious) with onset Nov2021, outcome "recovering", described as "HR 140s"; HYPERHIDROSIS (non-serious) with onset Nov2021, outcome "recovering", described as "diaphoretic"; FEELING ABNORMAL (non-serious) with onset Nov2021, outcome "recovering", described as "feeling "weird" in chest". The events "hr 140s", "diaphoretic" and "feeling "weird" in chest" were evaluated at the physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of heart rate increased, hyperhidrosis, feeling abnormal.  Additional info: Prior to vaccination, the patient was  not diagnosed with COVID-19. No known allergies. No other medications received within 2 weeks of vaccination. Patient stated, Aprox 2 weeks after 1st dose, aprox 7 days of episodes 1-2 a day, HR 140s, diaphoretic, feeling "weird" in chest. On 3rd day of occurrence went to ED, EKG performed which showed T wave changes, performed Cardiac labs, all negative. D/c home, episode occurred for few more nights then stopped.   No follow-up attempts are possible. No further information is expected.  Follow-Up (14Dec2021): Follow-up attempts are completed. No further information is expected.
"I" have rash with swelling all over "my" face and neck; "I" have rash with swelling all over "my" face and neck; "I" have rash with swelling all over "my" face and neck; This is a spontaneous report from a non-contactable consumer, the patient. A 44-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF2590) via an unspecified route of administration in the left arm on 16Oct2021 at 15:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included lactobacillus nos (CULTURELLE) (reported as culturelle probiotic) and multivitamin (MANUFACTURER UNKNOWN); both from unknown date for unknown indication and unknown if ongoing. On 17Oct2021 at 01:00, the patient experienced rash with swelling all over her face and neck and the patient never had facial filers. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events she had rash with swelling all over face and neck was not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
I had a lot of muscle pain, joint (like flu symptoms) and lips went numb lasting less than 24 hours. I took two Tylenol and I was fine after that.
Pt claims inability to raise arm sometimes but excruciating pain that is now radiating to the shoulder. The injection site appears normal but the muscle can be swollen at times. The pain is worse in the middle of the night and is slightly relieved by aspirin/ibuprofen/ice/heat/ or muscle rubs. All symptoms appeared 1 week or more after injection.
rt thigh @ inj site 3 1/2 x 4cm circular local erythema, mild tenderness;
Patient called into clinic to report that today she started to get rash and hives on her legs, butt and back area. She reports that this did happen after her second dose but was not sure if it was related to the vaccine, since it occurred days after the vaccine.  Patient is advised to take antihistamine Rx at home, monitor symptoms, ER precautions given and call back to clinic as needed for f/u care.
I got hives after both shots.... the first was on 4/14/21 and got hives 5 days later...  they never went away. The second covid19 shot was 5/5/21 and 2 days after the hives flared up again! They have never gone away!! Mostly on my legs and arms...
~3PM Immediately after injection - intense pain at site of injection. Several minutes after injection - lightheadedness.  ~10PM - sudden overwhelming full body symptoms. Started with lightheadedness, fever, headache, and nausea. After laying in bed, the headache became extremely painful/throbbing. Full body aches (back, neck, legs) began. Ears got sensitive to sound, eyes got sensitive to light. Stayed in bed experiencing pain until ~1 pm the next day. After taking aleve around 11 am, the headache and fever subsidized, but the remainder of symptoms still persist.
pt recv vax 14JUL97 & pt noted redness, swelling & pain which worsened on 25JUL;seen in clinic w/obvious cellulitis;
a dose of the Moderna Covid-19 vaccine administered to a pediatric patient; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (a dose of the Moderna Covid-19 vaccine administered to a pediatric patient) in a 14-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (a dose of the Moderna Covid-19 vaccine administered to a pediatric patient). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (a dose of the Moderna Covid-19 vaccine administered to a pediatric patient) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The  Caller who is a Pharmacy Director wants recommendation for a dose of the Moderna Covid-19 vaccine administered to pediatric patients aged 17-year-old and 14 year old. Caller does not have any patient specific information on either of the patients; he just wants recommendation on what to do.  No concomitant medication details were provided. No treatment medication details were provided.   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Non-significant follow-up
pregnant patient (unknown gestation) received GSK's RSVPreF3; received GSK's RSVPreF3, adjuvanted OA vaccine rather than Abrysvo; This non-serious prospective pregnancy case was reported by a other health professional and described the occurrence of vaccine exposure during pregnancy in a female patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   On an unknown date, the patient received Arexvy .5 ml. On an unknown date, an unknown time after receiving Arexvy, the patient experienced vaccine exposure during pregnancy (Verbatim: pregnant patient (unknown gestation) received GSK's RSVPreF3 ) and wrong vaccine administered (Verbatim: received GSK's RSVPreF3, adjuvanted OA vaccine rather than Abrysvo).  The outcome of the vaccine exposure during pregnancy and wrong vaccine administered were unknown.   Pregnancy exposure: Pregnancy Exposure (Arexvy): Trimester unknown Pregnancy Outcome: Pregnancy was ongoing   Additional Information: GSK receipt date: 12-Oct-2023 Patient information was unknown.  This was reported to VAERS (unknown when).  The reporter was reporting this after learning of the error during a presentation and speaking with CDC speaker who shared that it was reported to VAERS (but not informed of specific details). The reporter did not consent to follow-up. Pregnant patient received Arexvy (GSK's RSVPreF3, adjuvanted OA vaccine) rather than Abrysvo (maternal RSV vaccine), which led to vaccine exposure during pregnancy and wrong vaccine administered.